Atrás
Rango del Día
$448.49
$471.72
Rango de 52 Semanas
$265.00
$615.00
Volumen
294,274
Promedio 50D / 200D
$468.57
/
$437.29
Cierre Anterior
$445.04
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -36.8 | 0.2 |
| P/B | 17.6 | 3.0 |
| ROE % | -42.5 | 3.6 |
| Net Margin % | -30.1 | 3.8 |
| Rev Growth 5Y % | — | 9.9 |
| D/E | 0.6 | 0.2 |
Precio Objetivo de Analistas
Hold
$705.67
+52.8%
Low: $527.00
High: $964.00
EPS Futuro
-$4.49
Ingresos Est.
1.48B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$70.33
$59.58 – $79.31
|
4.87B | 4 |
| FY2029 |
$49.53
$41.96 – $55.85
|
3.90B | 4 |
| FY2028 |
$31.37
$16.07 – $49.15
|
2.99B | 11 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-19 | -$0.90 | -$2.57 | -187.1% |
| 2025-11-04 | -$2.04 | -$5.08 | -149.4% |
| 2025-08-05 | -$3.48 | -$1.90 | +45.4% |
| 2025-05-01 | -$3.62 | -$3.32 | +8.3% |
| 2025-02-26 | -$4.32 | -$2.71 | +37.3% |
| 2024-10-31 | -$6.94 | -$4.92 | +29.1% |
| 2024-08-07 | -$7.55 | -$7.10 | +6.0% |
| 2024-05-07 | -$6.06 | -$7.38 | -21.8% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Puntos Clave
Negative free cash flow of -190.02M
Capital efficient — spends only 0.05% of revenue on capex
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)432.05%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-42.49%
ROIC-23.52%
Net Margin-30.08%
Op. Margin-31.31%
Seguridad
Debt / Equity
0.59
Current Ratio4.01
Interest Coverage-13.45
Valoración
P/E Ratio
-36.76
Forward P/EN/A
P/B Ratio17.58
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 432.05% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 958.40M | Net Income (TTM) | -288.28M |
| ROE | -42.49% | ROA | -22.89% |
| Gross Margin | 94.14% | Operating Margin | -31.31% |
| Net Margin | -30.08% | Free Cash Flow (TTM) | -190.02M |
| ROIC | -23.52% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.59 | Current Ratio | 4.01 |
| Interest Coverage | -13.45 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -36.76 | Forward P/E | N/A |
| P/B Ratio | 17.58 | P/S Ratio | 11.06 |
| PEG Ratio | 1.10 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | 21.05 |
| Forward P/S | 7.15 | Fwd Earnings Yield | N/A |
| FCF Yield | -1.79% | ||
| Market Cap | 10.60B | Enterprise Value | 10.75B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 958.40M | 180.13M | 0.0 | 0.0 | 0.0 |
| Net Income | -288.28M | -465.89M | -373.63M | -295.35M | -241.85M |
| EPS (Diluted) | -12.85 | -21.90 | -19.99 | -17.23 | -14.63 |
| Gross Profit | 902.26M | 173.90M | 0.0 | 0.0 | 0.0 |
| Operating Income | -300.10M | -497.88M | -380.50M | -293.57M | -242.48M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.26B | 1.04B | 640.55M | 362.57M | 273.33M |
| Total Liabilities | 656.90M | 287.86M | 235.21M | 165.18M | 77.23M |
| Shareholders' Equity | 602.69M | 754.38M | 405.33M | 197.39M | 196.11M |
| Total Debt | 354.36M | 119.57M | 117.19M | 49.89M | 797,000.0 |
| Cash & Equivalents | 198.69M | 100.02M | 99.92M | 331.55M | 36.27M |
| Current Assets | 1.25B | 1.03B | 637.28M | 361.37M | 271.68M |
| Current Liabilities | 310.29M | 169.28M | 118.55M | 115.89M | 76.84M |